BSGM — Biosig Technologies Cashflow Statement
0.000.00%
Last trade - 00:00
- $15.79m
- $15.63m
- $0.02m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -34.5 | -59.1 | -32.9 | -27.3 | -28.7 |
Depreciation | |||||
Non-Cash Items | 19 | 30.1 | 9.71 | 4.8 | 10.2 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.072 | 2.35 | -3.45 | 0.464 | 0.769 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | -15.5 | -26.6 | -26.4 | -21.7 | -17.3 |
Capital Expenditures | -0.289 | -0.087 | -0.542 | -0.168 | -0.186 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.003 | 0 | — | — | — |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -0.286 | -0.087 | -0.542 | -0.168 | -0.186 |
Financing Cash Flow Items | 5.01 | 10.6 | 0 | — | 1.97 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 23.4 | 42.8 | 10.3 | 10.6 | 17.3 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 7.66 | 16.2 | -16.6 | -11.3 | -0.167 |